Highlights
•
SARS-CoV-2 spike protein persists in the skull-meninges-brain axis in COVID-19 patients
•
Spike protein is sufficient to induce brain pathological and behavioral changes in mice
•
Spike protein enhances brain vulnerability and exacerbates neurological damage in mice
•
mRNA vaccines reduce, but do not eliminate, the spike burden
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.